# Effect of High-fat Meal on the Pharmacokinetics of TQ-B3139 Capsules

> **NCT04675060** · PHASE1 · UNKNOWN · sponsor: **Chia Tai Tianqing Pharmaceutical Group Co., Ltd.** · enrollment: 12 (estimated)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** TQ-B3139 capsules

## Key facts

- **NCT ID:** NCT04675060
- **Lead sponsor:** Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-02-23
- **Primary completion:** 2022-03-01
- **Final completion:** 2022-03-01
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2021-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04675060

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04675060, "Effect of High-fat Meal on the Pharmacokinetics of TQ-B3139 Capsules". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04675060. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*